V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20063853 | 20169632 | 1.66 | 74 | Curative (C) | 2016-01-08 | 2016-01-29 | null | 02 | Y | OXALIPLATIN | 101153977 |
| 20063925 | 20169633 | 1.7 | 72 | null | 2020-10-21 | 2020-11-09 | null | 02 | null | LENALIDOMIDE | 101772865 |
| 20064427 | 20169635 | 1.83 | 65.9 | null | 2017-06-06 | 2018-08-13 | null | 02 | null | OXALIPLATIN | 101817598 |
| 20064608 | 20169636 | null | 56.2 | Neo-adjuvant (N) | 2019-12-18 | 2020-01-10 | null | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101795504 |
| 20065230 | 20169637 | null | 95.8 | Curative (C) | 2021-04-10 | 2021-04-24 | null | 02 | N | ABIRATERONE | 101587740 |
| 20065474 | 20169638 | 1.91 | 66.7 | Palliative (P) | 2020-02-12 | 2020-11-25 | null | 2 | N | CISPLATIN | 100647715 |
| 20065823 | 20169640 | 1.66 | 75.4 | null | null | 2020-02-24 | LU-177 | 02 | null | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100850182 |
| 20065973 | 20169641 | 1.75 | 59 | Palliative (P) | 2016-11-26 | 2016-12-10 | null | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101023012 |
| 20066065 | 20169642 | 1.68 | 89 | null | 2020-11-23 | 2020-11-27 | Everolimus 10mg | 02 | null | EVEROLIMUS | 101436996 |
| 20066336 | 20169643 | 1.8 | 0 | Palliative (P) | 2020-04-08 | 2020-04-09 | CAPECITABINE + CARBOPLATIN + Trastuzumab | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100683337 |
| 20066495 | 20169645 | 1.62 | 58 | null | 2022-04-07 | 2022-04-14 | EVEROLIMUS | 02 | null | EVEROLIMUS | 101230888 |
| 20066571 | 20169646 | 1.82 | 64.3 | null | 2021-06-28 | 2021-12-16 | null | 02 | null | LUTETIUM-177 | 100904687 |
| 20067069 | 20169647 | 1.89 | 110 | Adjuvant (A) | 2020-01-03 | 2020-01-04 | null | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100962822 |
| 20067991 | 20169649 | 1.74 | 66.6 | Neo-adjuvant (N) | null | 2016-05-28 | null | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100025544 |
| 20068083 | 20169650 | 1.56 | 71.5 | null | 2022-03-31 | 2022-04-15 | null | 02 | null | LENALIDOMIDE | 100227267 |
| 20068190 | 20169651 | 1.54 | 56.6 | Adjuvant (A) | 2022-03-23 | 2022-05-19 | null | 02 | N | TRIFLURIDINE + TIPIRACIL | 100553853 |
| 20069155 | 20169652 | 1.6 | null | Palliative (P) | 2020-07-12 | 2020-08-05 | null | N | N | CARBOPLATIN + FLUOROURACIL | 101117936 |
| 20069324 | 20169653 | 1.8 | 57.6 | 03 | null | 2019-06-28 | null | N | N | ENZALUTAMIDE | 100851664 |
| 20069791 | 20169654 | 1.63 | 58.5 | null | 2021-04-21 | 2021-04-28 | null | 02 | null | TRIFLURIDINE + TIPIRACIL | 100948501 |
| 20070046 | 20169655 | 1.75 | 95 | null | 2016-11-12 | 2021-11-28 | null | 02 | null | EVEROLIMUS | 101510317 |
| 20070301 | 20169656 | 1.71 | null | Palliative (P) | 2019-04-26 | 2019-04-26 | null | 02 | N | OCTREOTIDE | 100523326 |
| 20070382 | 20169657 | 1.63 | null | null | 2017-04-15 | 2017-06-24 | null | 02 | null | MITOMYCIN INTRAVESICULAR | 100340739 |
| 20070652 | 20169659 | 1.83 | 62.8 | Neo-adjuvant (N) | 2020-05-05 | 2020-06-17 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | null | PEMBROLIZUMAB + PEMETREXED | 101336423 |
| 20073374 | 20169661 | null | 46.15 | Neo-adjuvant (N) | 2020-03-25 | 2022-04-01 | Obinutuzumab | 02 | null | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 101601864 |
| 20074761 | 20169663 | null | null | Neo-adjuvant (N) | 2020-03-13 | 2020-04-03 | FOXTROT TRIAL | null | N | ARISTOTLE TRIAL | 101565676 |
| 20075366 | 20169664 | 1.84 | 51.1 | Palliative (P) | 2021-01-06 | 2021-01-25 | Hydroxycarbamide | 02 | N | CAV | 100783629 |
| 20078310 | 20169666 | 1.8 | 90 | Adjuvant (A) | 2017-03-17 | 2017-04-10 | CHOP R - 21 days | N | N | CARBO + FLUOROURACIL | 100647413 |
| 20078460 | 20169667 | 1.69 | 87 | Palliative (P) | 2019-08-28 | 2019-09-15 | Niraparib | 02 | null | TEMOZOLOMIDE | 100966912 |
| 20078985 | 20169668 | 1.55 | 83.3 | 03 | null | 2020-02-25 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | MITOMYCIN | 100782911 |
| 20080353 | 20169670 | 1.72 | 56.2 | Palliative (P) | 2020-02-13 | 2020-02-21 | CISPLATIN + FLUOROURACIL + RT | 02 | N | DERAZANTINIB | 100887597 |
| 20084150 | 20169671 | 1.81 | 93.2 | Adjuvant (A) | null | 2017-04-06 | Venetoclax | 99 | N | IRINOTECAN + RALTITREXED | 100861511 |
| 20084757 | 20169674 | 1.8 | 111.3 | Neo-adjuvant (N) | null | 2019-04-19 | PEG INTERFERON | null | null | EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE | 100877133 |
| 20085579 | 20169676 | 1.75 | 111 | Palliative (P) | 2016-03-13 | 2016-04-18 | CAPECITABINE + IRINOTECAN + Panitumumab | 2 | null | VINORELBINE | 100299022 |
| 20086794 | 20169677 | 1.57 | 72.5 | null | 2021-11-03 | 2021-11-03 | Pemetrexed | 01 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100342773 |
| 20090331 | 20169678 | 1.69 | 83.9 | Palliative (P) | 2018-04-11 | 2018-05-24 | SCOPE 2 TRIAL | 02 | N | ANAGRELIDE | 101204687 |
| 20091883 | 20169679 | 0 | 92.5 | null | null | 2020-08-26 | FLUDARABINE | null | N | AZACITIDINE | 101495733 |
| 20092119 | 20169680 | 1.57 | 91 | Palliative (P) | 2022-03-17 | 2022-03-31 | Bevacizumab + Capecitabine | N | N | TEMOZOLOMIDE | 101310999 |
| 20092250 | 20169681 | 1.71 | 85 | Neo-adjuvant (N) | 2021-05-29 | 2021-06-21 | INTERAACT trial | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101555793 |
| 20092372 | 20169682 | 1.51 | 108.9 | null | 2021-09-30 | 2021-10-07 | IPILIMUMAB + NIVOLUMAB | 02 | null | AVELUMAB + AXITINIB | 101615191 |
| 20092505 | 20169683 | 1.83 | 100.6 | Adjuvant (A) | 2021-05-22 | 2021-05-28 | CHOP R - 21 days | 02 | N | HYDROXYCARBAMIDE | 100962493 |
| 20095656 | 20169686 | 1.62 | 56 | Palliative (P) | 2021-10-04 | 2021-10-24 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | TRABECTEDIN | 100480046 |
| 20102709 | 20169688 | 1.8 | 76.3 | Palliative (P) | 2018-11-22 | 2018-11-26 | CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL + Trastuzumab | 02 | null | CAPECITABINE + CETUXIMAB + OXALIPLATIN | 100699180 |
| 20102753 | 20169689 | 1.65 | 152 | null | null | 2022-03-08 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101169511 |
| 20103311 | 20169690 | 1.8 | 47.5 | null | 2020-02-07 | 2020-02-21 | Bortezomib + MELPHALAN | 02 | N | CISPLATIN + VINORELBINE | 100700222 |
| 20104579 | 20169691 | 1.81 | 68.7 | Palliative (P) | 2019-06-09 | 2019-06-27 | Cisplatin +FU +Trastuzumab - Load | 02 | N | IXAZOMIB + LENALIDOMIDE | 101197827 |
| 20104849 | 20169693 | 1.69 | 63 | null | 2021-11-24 | 2021-12-09 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101653900 |
| 20105167 | 20169694 | 1.69 | 59.05 | Palliative (P) | 2020-12-09 | 2021-01-15 | Encorafenib | 01 | N | LIPOSOMAL DOXORUBICIN | 101586936 |
| 20105865 | 20169696 | 1.58 | 87.4 | Palliative (P) | null | 2018-09-07 | Carboplatin + Fluorouracil + Streptozocin | 02 | N | CAPECITABINE + STREPTOZOCIN | 100094039 |
| 20106119 | 20169697 | 1.75 | 69.6 | Neo-adjuvant (N) | 2017-09-26 | 2017-09-28 | Cisplatin +FU +Trastuzumab - Load | 02 | N | BORTEZOMIB | 101121579 |
| 20106237 | 20169698 | 1.52 | 75.8 | Palliative (P) | 2019-03-06 | 2019-03-08 | IBRUTINIB | 02 | null | FOCUS4 TRIAL | 100563912 |